Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos One|August 11, 2025
The FGFR inhibitor pemigatinib overcomes cancer drug resistance to KRAS G12C inhibitors in mesenchymal lung cancerAngela Abdollahi, Margaret Favata, Michael Weber, et al.
Oncotarget|October 15, 2017
Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequencyJoseph Dosch, Elizabeth Ziemke, Shanshan Wan, et al.
Cancer Research|March 12, 2017
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple ImmunotherapiesJonathan Rios-Doria, Jay Harper, Raymond Rothstein, et al.
Oncoimmunology|September 14, 2016
Targeting CD73 in the tumor microenvironment with MEDI9447Carl M Hay, Erin Sult, Qihui Huang, et al.
Frontiers in Oncology|January 11, 2021
A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted ActivityJonathan Rios-Doria, Margaret Favata, Kerri Lasky, et al.
Molecular Cancer Therapeutics|May 8, 2015
A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated PathwaysJonathan Rios-Doria, Darrin Sabol, Jon Chesebrough, et al.
Cancer Discovery|March 7, 2022
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 InhibitorHolly K Koblish, Liangxing Wu, Liang-Chuan S Wang, et al.
Pageof 2